In this interview, Robert Durham gives an overview of the new Gyrolab® xPand from Gyros Protein Technologies, presented at WRIB this year.
Browsing: Drug development
The future of individualized medicine: intensified decentralized biotherapeutic production in combination with state-of-the-art diagnostics of the next generation
In this editorial the future of individualized medicine is reviewed, focusing on the decentralization of biotherapeutic production in combination with state-of-the-art diagnostics of the next generation.
Validated UHPLC–MS/MS method for quantification of doxycycline in abdominal aortic aneurysm patients
Read more about this development and validation of a selective, specific, simple and rapid UHPLC–MS/MS method for doxycycline, in our featured article from Bioanalysis.
View webinar on demand.
This webinar will highlight recent advances in metabolomics for pharmaceutical research, drug development and precision medicine.
Read more about the valdiation of an ELISA to investigate the pharmacokinetics and concentration–response relationship of panitumumab, in this article from Bioanalysis.
Quantitative whole body autoradiography (QWBA) and imaging mass spectrometry (IMS): can IMS replace QWBA to support regulated drug discovery and development
Read time: 4:45 mins
Eric Solon (Madrigal Pharmaceuticals; PA, USA) discusses whether or not IMS can replace QWBA as the technique of choice when examining the disposition of new drug and biotherapeutic entities.
Read/watch time: 3 mins
Learn more about the field of lipidomics in this FAQ style ‘Ask the Editor’ article about the fundamentals of lipidomic analysis.
Now available on demand Liposomes, used as carriers for drug delivery, encapsulate and protect the…
A team from the University of Toronto (ON, Canada) has developed a method to produce geometric isoforms of drugs, potentially leading to improved efficiency.
Researchers have demonstrated that small molecules mimicking activated protein C could provide anti-inflammatory and anti-thrombotic protection without interfering with blood clotting, becoming attractive drug candidates.